Press Releases

    • MAY 05 2020

    Oncoceutics Commemorates Brain Tumor Awareness Month

    Philadelphia, PA (May 5, 2020) – Oncoceutics, a clinical-stage drug discovery and development company, commemorates Brain Tumor Awareness Month this May and expresses its support for all those affected by brain tumors. Brain tumors remain one of the greatest current health challenges as there are limited treatment options for patients, and prognoses continue to be

    • APR 07 2020

    Co-Founder and CEO Wolfgang Oster Departs from Oncoceutics

    Philadelphia, PA (April 7, 2020) – Oncoceutics, Inc., a clinical-stage drug discovery and development company with a novel class of compounds called imipridones, announced today that Wolfgang Oster, MD, PhD, one of the company’s co-founders and Chief Executive Officer, has left the company effective April 3 as part of a leadership change.  He has also